Advertisement

European Radiology

, Volume 29, Issue 12, pp 7019–7026 | Cite as

Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management?

  • Thomas Duchaussoy
  • Jean-François Budzik
  • Laurene Norberciak
  • Lucie Colas
  • Marta Pasquini
  • Sebastien VerclytteEmail author
Neuro
  • 174 Downloads

Abstract

Objectives

FLAIR-DWI mismatch is an effective method to select eligible wake-up stroke (WUS) patients for intravenous thrombolysis, but shows limitations in the case of subtle FLAIR hyperintensities. T2 mapping is a quantitative method, directly generated from synthetic MRI, which provides T2 relaxation times. We aimed to assess the correlation between T2 values and onset time in acute stroke patients.

Methods

We prospectively included stroke patients in the 4.5-h window undergoing brain MRI including MAGnetic resonance Image Compilation (MAGiC) from March to October 2017. T2 relaxation times and FLAIR signal intensities were measured in ischemic and contralateral nonischemic regions to calculate FLAIR signal intensity ratio (rSI), difference, and ratio of T2 values. Correlation analysis with time from the onset was achieved using Pearson or Spearman correlation coefficient (ρ) test.

Results

Forty-two patients were included. The strongest correlation with the time from onset was the difference in T2 relaxation times (ρ = 0.71; CI95% = [0.48; 0.85]), followed by the ratio (ρ = 0.65; CI95% = [0.37; 0.82]) and the absolute T2 relaxation time (ρ = 0.4; CI95% = [0.06; 0.66]), whereas the FLAIR rSI showed the weakest correlation (ρ = 0.18; CI95% = [− 0.16–0.51]).

Conclusions

The difference and ratio in T2 relaxation times were correlated with the onset time in stroke patients in the 4.5-h window. T2 mapping generated from synthetic MRI may become a relevant tool to select WUS patients with subtle FLAIR hyperintensities. Given that no definitive statement can be made about its usefulness in the 4.5-h windows, further study including patients with an onset time > 4.5 h is required.

Key Points

• The difference and ratio in T2 relaxation times are each individually correlated with the time from stroke onset in the 4.5-h window.

• FLAIR rSI showed a poor correlation with the time from stroke onset.

• T2 mapping, directly generated from synthetic MRI, may be a suitable quantitative marker to select safely WUS patients with subtle FLAIR hyperintensities for intravenous thrombolysis.

Keywords

Stroke Acute stroke Magnetic resonance imaging 

Abbreviations

MAGiC

MAGnetic resonance Imaging Compilation

NIHSS

National Institutes of Health Stroke Scale

rSI

Signal intensity ratio

WUS

Wake-up stroke

Notes

Funding

The authors state that this work has not received any funding.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Pr Sebastien Verclytte.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Prospective

• Observational

• Performed at one institution

References

  1. 1.
    Mackey J, Kleindorfer D, Sucharew H et al (2011) Population-based study of wake-up strokes. Neurology 76:1662–1667.  https://doi.org/10.1212/WNL.0b013e318219fb30 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Thomalla G, Boutitie F, Fiebach JB et al (2017) Stroke with unknown time of symptom onset: baseline clinical and magnetic resonance imaging data of the first thousand patients in WAKE-UP (efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomized, doubleblind, placebo-controlled trial). Stroke 48:770–773.  https://doi.org/10.1161/STROKEAHA.116.015233 CrossRefPubMedGoogle Scholar
  3. 3.
    Powers WJ, Rabinstein AA, Ackerson T et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 49:e46–e99.  https://doi.org/10.1161/STR.0000000000000158 CrossRefPubMedGoogle Scholar
  4. 4.
    Nogueira RG, Jadhav AP, Haussen DC et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21.  https://doi.org/10.1056/NEJMoa1706442 CrossRefPubMedGoogle Scholar
  5. 5.
    Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718.  https://doi.org/10.1056/NEJMoa1713973 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Thomalla G, Simonsen CZ, Boutitie F et al (2018) MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med.  https://doi.org/10.1056/NEJMoa1804355
  7. 7.
    Petkova M, Rodrigo S, Lamy C et al (2010) MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 257:782–792.  https://doi.org/10.1148/radiol.10100461 CrossRefPubMedGoogle Scholar
  8. 8.
    Ebinger M, Galinovic I, Rozanski M, Brunecker P, Endres M, Fiebach JB (2010) Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock? Stroke 41:250–255.  https://doi.org/10.1161/STROKEAHA.109.568410
  9. 9.
    Cheng B, Brinkmann M, Forkert ND et al (2013) Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab 33:76–84.  https://doi.org/10.1038/jcbfm.2012.129 CrossRefPubMedGoogle Scholar
  10. 10.
    Blystad I, Warntjes JBM, Smedby Ö, Lundberg P, Larsson EM, Tisell A (2017) Quantitative MRI for analysis of peritumoral edema in malignant gliomas. PLoS One 12:e0177135.  https://doi.org/10.1371/journal.pone.0177135
  11. 11.
    Namer IJ, Waydelich R, Armspach JP, Hirsch E, Marescaux C, Grucker D (1998) Contribution of T2 relaxation time mapping in the evaluation of cryptogenic temporal lobe epilepsy. Neuroimage 7:304–313.  https://doi.org/10.1006/nimg.1998.0331
  12. 12.
    Jackson GD, Connelly A, Duncan JS, Grünewald RA, Gadian DG (1993) Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 43:1793–1799Google Scholar
  13. 13.
    Rugg-Gunn FJ, Boulby PA, Symms MR, Barker GJ, Duncan JS (2005) Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy. Neurology 64:318–325.  https://doi.org/10.1212/01.WNL.0000149642.93493.F4
  14. 14.
    Bonnier G, Maréchal B, Fartaria MJ et al (2017) The combined quantification and interpretation of multiple quantitative magnetic resonance imaging metrics enlightens longitudinal changes compatible with brain repair in relapsing-remitting multiple sclerosis patients. Front Neurol 8:506.  https://doi.org/10.3389/fneur.2017.00506 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Hagiwara A, Hori M, Yokoyama K et al (2017) Synthetic MRI in the detection of multiple sclerosis plaques. AJNR Am J Neuroradiol 38:257–263.  https://doi.org/10.3174/ajnr.A5012 CrossRefPubMedGoogle Scholar
  16. 16.
    Norton TJT, Pereyra M, Knight MJ et al (2017) Stroke onset time determination using MRI relaxation times without non-ischaemic reference in a rat stroke model. Biomed Spectrosc Imaging 6:25–35.  https://doi.org/10.3233/BSI-160155 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Siemonsen S, Mouridsen K, Holst B et al (2009) Quantitative t2 values predict time from symptom onset in acute stroke patients. Stroke 40:1612–1616.  https://doi.org/10.1161/STROKEAHA.108.542548 CrossRefPubMedGoogle Scholar
  18. 18.
    Blystad I, Håkansson I, Tisell A et al (2016) Quantitative MRI for analysis of active multiple sclerosis lesions without gadolinium-based contrast agent. AJNR Am J Neuroradiol 37:94–100.  https://doi.org/10.3174/ajnr.A4501 CrossRefPubMedGoogle Scholar
  19. 19.
    Siemonsen S, Löbel U, Sedlacik J et al (2012) Elevated T2-values in MRI of stroke patients shortly after symptom onset do not predict irreversible tissue infarction. Brain 135:1981–1989.  https://doi.org/10.1093/brain/aws079
  20. 20.
    Tanenbaum LN, Tsiouris AJ, Johnson AN et al (2017) Synthetic MRI for clinical neuroimaging: results of the magnetic resonance image compilation (MAGiC) prospective, multicenter, multireader trial. AJNR Am J Neuroradiol 38:1103–1110.  https://doi.org/10.3174/ajnr.A5227 CrossRefPubMedGoogle Scholar
  21. 21.
    Hagiwara A, Hori M, Cohen-Adad J et al (2018) Linearity, bias, intrascanner repeatability, and interscanner reproducibility of quantitative multidynamic multiecho sequence for rapid simultaneous relaxometry at 3 T: a validation study with a standardized phantom and healthy controls. Invest Radiol 54:39–47.  https://doi.org/10.1097/RLI.0000000000000510
  22. 22.
    Brott T, Adams HP Jr, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870Google Scholar
  23. 23.
    Watanabe O, West CR, Bremer A (1977) Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 2: effects on brain water and electrolytes in the early phase of MCA stroke. Stroke 8:71–76CrossRefGoogle Scholar
  24. 24.
    Wansapura JP, Holland SK, Dunn RS, Ball WS Jr (1999) NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging 9:531–538Google Scholar
  25. 25.
    Thomalla G, Cheng B, Ebinger M et al (2011) DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 10:978–986.  https://doi.org/10.1016/S1474-4422(11)70192-2 CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2019

Authors and Affiliations

  1. 1.Imaging Department, Lille Catholic HospitalsLille Catholic UniversityLilleFrance
  2. 2.Biostatistics Department - Delegations for Clinical Research and Innovation, Lille Catholic HospitalsLille Catholic UniversityLilleFrance
  3. 3.Department of Neurology, Lille Catholic HospitalsLille Catholic UniversityLilleFrance

Personalised recommendations